Clinical Trial Update: Coagulopathy of Immunodermatologic Diseases

View source ↗

Summary

A clinical trial update shows a study on coagulopathy in immunodermatologic diseases is currently recruiting, sponsored by the University of Nebraska.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Bullous Dermatosis

Snippet

Sponsor: University of Nebraska | Conditions: Autoimmune Bullous Dermatosis | Status: RECRUITING